MyeloDysplastic Syndromes: our syndicated research will tell you why - and how - treatment paradigms are changing. Our results from first 2 waves conducted are available now and field is running for the 3rd wave.
The second interview with our AplusA employees is here!
This year, AplusA is celebrating its 30+...
La deuxième interview de nos collaborateurs AplusA est là !
En 2021, AplusA fête - non pas ses...
Digital, Social Media Listening
Social data analytics, social media research, online market research, social media listening, ...
Consciente de l’importance que représente la mixité professionnelle, qui est un facteur...
All of our countries implemented sanitary measures for stopping the global Covid-19 pandemic:...
In ‘21, we are celebrating our 30+.
AplusA is actually 30+ years old this year... But what does...
C’est l’année 21, mais nous en célébrons plus de 30.
En 2021, AplusA fête - non pas ses 30 -...
Our range of syndicated studies now covers over 30 indications, many of them with results...
hemato-oncology, COVID-19, Syndicated Studies, Oncology
How does COVID-19 affect the HCPS relationships with patients and with the pharmaceutical...